BOSTON, Dec. 7, 2023
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced
that Chris Simon, President and CEO,
will present at the 42nd Annual J.P. Morgan Healthcare
Conference in San Francisco on
Tuesday, January 9, 2024 at
9:45am Pacific time.
The public may access Mr. Simon's presentation live via audio
webcast at:
https://jpmorgan.metameetings.net/events/healthcare24/sessions/49347-haemonetics-corporation/webcast?gpu_only=true&kiosk=true
The live webcast can also be accessed under the Events &
Presentations section of the Company's Investor Relations website.
The replay of the presentation will be available for 30 days using
the link provided above and on Investor Relations website shortly
after the live event.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global
healthcare company dedicated to providing a suite of innovative
medical products and solutions for customers, to help them improve
patient care and reduce the cost of healthcare. Our technology
addresses important medical markets: blood and plasma component
collection, the surgical suite and hospital transfusion services.
To learn more about Haemonetics, visit www.haemonetics.com.
Investor
Contacts:
|
|
Olga Guyette, Sr.
Director-Investor Relations & Treasury
|
David Trenk,
Manager-Investor Relations
|
(781)
356-9763
|
(203)
733-4987
|
olga.guyette@haemonetics.com
|
david.trenk@haemonetics.com
|
|
|
Media
Contact: Josh Gitelson, Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-42nd-annual-jp-morgan-healthcare-conference-302009459.html
SOURCE Haemonetics Corporation